Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
July 31, 2026 19.28%
April 30, 2026 18.47%
January 31, 2026 16.96%
October 31, 2025 23.32%
July 31, 2025 19.33%
April 30, 2025 12.89%
January 31, 2025 18.92%
October 31, 2024 20.63%
July 31, 2024 17.87%
April 30, 2024 19.58%
January 31, 2024 20.99%
October 31, 2023 28.14%
July 31, 2023 6.64%
April 30, 2023 17.59%
January 31, 2023 20.05%
October 31, 2022 19.90%
July 31, 2022 19.15%
April 30, 2022 17.05%
January 31, 2022 16.91%
October 31, 2021 26.63%
July 31, 2021 16.65%
April 30, 2021 14.16%
January 31, 2021 18.60%
October 31, 2020 14.97%
July 31, 2020 15.78%
Date Value
April 30, 2020 8.16%
January 31, 2020 14.52%
October 31, 2019 14.19%
July 31, 2019 14.99%
April 30, 2019 14.70%
January 31, 2019 39.25%
October 31, 2018 15.07%
July 31, 2018 19.62%
April 30, 2018 17.00%
January 31, 2018 -26.42%
October 31, 2017 14.89%
July 31, 2017 15.71%
April 30, 2017 14.88%
January 31, 2017 15.75%
October 31, 2016 11.16%
July 31, 2016 11.88%
April 30, 2016 8.93%
January 31, 2016 11.96%
October 31, 2015 13.53%
July 31, 2015 10.36%
April 30, 2015 9.14%
January 31, 2015 9.94%
October 31, 2014 0.77%
July 31, 2014 6.24%
April 30, 2014 8.03%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 14.52%
Danaher Corp. 13.89%
Illumina, Inc. 17.83%
Bio-Rad Laboratories, Inc. 57.05%
Revvity, Inc. 7.33%